Zobrazeno 1 - 6
of 6
pro vyhledávání: '"N. D. Wagner"'
Publikováno v:
Brain Pathology. 24:197-200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6296b782b1194428a63f74a6ac7525ae
https://doi.org/10.1111/bpa.12124
https://doi.org/10.1111/bpa.12124
Autor:
N L, Bartlett, G R, Petroni, B A, Parker, N D, Wagner, J P, Gockerman, G A, Omura, G P, Canellos, M, Robert, J L, Johnson, B A, Peterson
Publikováno v:
Cancer. 92(2)
To address the feasibility and outcome of moderate dose intensification with granulocyte-colony stimulating factor (G-CSF) for patients with aggressive non-Hodgkin lymphoma (NHL), the Cancer and Leukemia Group B (CALGB) conducted two studies evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a856d31ca78771d896600d3f1a896ba9
https://pubmed.ncbi.nlm.nih.gov/11466671
https://pubmed.ncbi.nlm.nih.gov/11466671
Autor:
Dennis E. Hallahan, G. F. Laport, Ronald Sobecks, N. D. Wagner, Christopher K. Daugherty, Richard A. Larson
Publikováno v:
Bone marrow transplantation. 25(8)
Since approximately 30% of leukemia patients relapse after allogeneic BMT using total body irradiation (TBI)-based preparative regimens, treatment intensity may be suboptimal. The killing of leukemia cells is proportional to the radiation absorbed do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b57c411e9af153119d1409c55a77f001
https://pubmed.ncbi.nlm.nih.gov/10808200
https://pubmed.ncbi.nlm.nih.gov/10808200
Autor:
N L, Bartlett, N D, Wagner
Publikováno v:
Cancer chemotherapy and biological response modifiers. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0be5c7427e7c7d4369eb639ab591972
https://pubmed.ncbi.nlm.nih.gov/10800489
https://pubmed.ncbi.nlm.nih.gov/10800489
Autor:
N D, Wagner, V W, Quinones
Publikováno v:
Oncology nursing forum. 25(6)
To provide a comprehensive understanding of allogeneic peripheral blood stem cell transplantation (PBSCT), the new modality for treating advanced hematologic malignancies.Journal articles/abstracts, published literature, clinical experience.Growth fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9fb460591a19a0e041903bfd5d6c705
https://pubmed.ncbi.nlm.nih.gov/9679263
https://pubmed.ncbi.nlm.nih.gov/9679263
Autor:
Dave Johnson, Peter Martin, Christopher R. Flowers, Wayne R. Godfrey, Martin Dreyling, Brad S. Kahl, Gilles Salles, Pier Luigi Zinzani, Nina D. Wagner-Johnston, Sven de Vos, Kristie A. Blum, Langdon L. Miller, Daniel Li, Ajay K. Gopal, Andreas Viardot, Roger Dansey, Leanne Holes, Andre Goy, Stephen J. Schuster, Ian W. Flinn, Wojciech Jurczak, Andrew Davies
Background Phosphatidylinositol-3-kinase delta (PI3Kδ) mediates B-cell receptor signaling and microenvironmental support signals that promote the growth and survival of malignant B lymphocytes. In a phase 1 study, idelalisib, an orally active select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6ab90621f28d2352d942b8ef04bd83c
http://hdl.handle.net/11585/506404
http://hdl.handle.net/11585/506404
